[Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs]
- PMID: 17022718
- DOI: 10.1016/s1130-6343(06)73982-4
[Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs]
Abstract
Objective: To study the major mutations in genes CYP2C8 and CYP2C9, their frequency in populations of diverse ethnical descent, their analysis methods, and the major drugs with affected metabolism, with a special emphasis on NSAIDs.
Method: Repeated searches of Pubmed (January 1966-January 2006) and Scholar Google were performed. All searches were restricted to studies in humans, and papers not written in Spanish or English were excluded.
Results: Ten allelic variants of CYP2C8 and 24 of CYP2C have been reported. Not all of them exert a relevant effect on drug metabolism. In Caucasians 22% of CYP2C8 genes and 31% of CYP2C9 genes have mutations. In Asians fewer than 1% and nearly 3% are mutated, respectively. Major identification methods include endonuclease digestion, PCR, pyrosequencing, and microarrays. Not all NSAIDs are exclusive substrates for CYP2C8/9. The usefulness of allelic variant analysis varies with each individual drug. The risk for digestive hemorrhage associated with the CYP2C9 genotype is particularly relevant when using aceclofenac, celecoxib, diclofenac, ibuprofen, indomethacin, lornoxicam, piroxicam, or naproxen.
Conclusions: Although CYP2C8/9 activity plays an essential role in the metabolism of and clinical response to many NSAIDs, the use of pharmacogenomic techniques is not equally useful for all these drugs.
Similar articles
-
Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):607-20. doi: 10.1517/17425250902970998. Expert Opin Drug Metab Toxicol. 2009. PMID: 19422321 Review.
-
Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.Eur J Clin Pharmacol. 2008 Oct;64(10):967-70. doi: 10.1007/s00228-008-0508-4. Epub 2008 Jun 12. Eur J Clin Pharmacol. 2008. PMID: 18548238
-
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.Pharmacol Res. 2008 Jul;58(1):77-84. doi: 10.1016/j.phrs.2008.07.004. Epub 2008 Jul 23. Pharmacol Res. 2008. PMID: 18694831 Clinical Trial.
-
Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.Pharmacogenomics. 2015;16(9):939-48. doi: 10.2217/pgs.15.40. Epub 2015 Jun 30. Pharmacogenomics. 2015. PMID: 26122864
-
Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?Drug Metab Dispos. 2005 Nov;33(11):1567-75. doi: 10.1124/dmd.105.006452. Epub 2005 Aug 23. Drug Metab Dispos. 2005. PMID: 16118328 Review.
Cited by
-
Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.PLoS One. 2020 Aug 11;15(8):e0236297. doi: 10.1371/journal.pone.0236297. eCollection 2020. PLoS One. 2020. Update in: PLoS One. 2022 Dec 1;17(12):e0278411. doi: 10.1371/journal.pone.0278411. PMID: 32780750 Free PMC article. Updated. Clinical Trial.
-
Pharmacogenomics of acetylsalicylic acid and other nonsteroidal anti-inflammatory agents: clinical implications.Eur J Clin Pharmacol. 2013 Jul;69(7):1369-73. doi: 10.1007/s00228-013-1477-9. Epub 2013 Feb 24. Eur J Clin Pharmacol. 2013. PMID: 23435614 Review.
-
Cytochrome P450 interactions and clinical implication in rheumatology.Clin Rheumatol. 2014 Sep;33(9):1231-8. doi: 10.1007/s10067-014-2710-3. Epub 2014 Jun 14. Clin Rheumatol. 2014. PMID: 24924606 Review.
-
Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk.Front Genet. 2012 Dec 3;3:278. doi: 10.3389/fgene.2012.00278. eCollection 2012. Front Genet. 2012. PMID: 23420707 Free PMC article.